@article{e90e84e20e77494aaa0214e0d5e34ae8,
title = "Influenza vaccine, Guillain-Barr{\'e} syndrome, and chasing zero",
author = "Poland, {Gregory A.} and Jacobsen, {Steven J.}",
note = "Funding Information: Conflict of interest statement: Dr. Poland has offered consultative advice on novel influenza vaccine development to Merck & Co., Inc., Avianax, Theraclone Sciences, MedImmune LLC, Liquidia Technologies, Inc., Novavax, Novartis Vaccines and Therapeutics and PAXVAX, Inc. Dr. Jacobsen reports receiving research funding from Merck .",
year = "2012",
month = aug,
day = "31",
doi = "10.1016/j.vaccine.2012.06.093",
language = "English (US)",
volume = "30",
pages = "5801--5803",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "40",
}